Can I read Evaluating Tykerb for Breast Cancer on EtoBox?

Evaluating Tykerb for Breast Cancer by api-547400638 is a document available to read on EtoBox.

What is Evaluating Tykerb for Breast Cancer about?

Tykerb is a drug used for metastatic breast cancer patients with HER2 mutations, particularly after the failure of Trastuzumab. It works by inhibiting HER2 and EGFR receptors, leading to tumor suppression, and has shown a 40.8% response rate when combined with chemotherapy. Despite its side effects and high cost, the benefits of Tykerb in treating resistant cancer justify its continued production.

Author

api-547400638

Language

EN